Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 26, 2022

SELL
$46.5 - $79.14 $8.29 Million - $14.1 Million
-178,264 Reduced 43.64%
230,239 $10.9 Million
Q2 2022

Jul 07, 2022

BUY
$63.06 - $84.75 $571,008 - $767,411
9,055 Added 2.27%
408,503 $29.3 Million
Q1 2022

Apr 12, 2022

BUY
$74.15 - $99.36 $10.5 Million - $14.1 Million
142,205 Added 55.28%
399,448 $32.3 Million
Q4 2021

Feb 15, 2022

SELL
$86.01 - $102.89 $1.09 Million - $1.31 Million
-12,728 Reduced 4.71%
257,243 $26.4 Million
Q3 2021

Nov 03, 2021

BUY
$84.7 - $96.31 $1.69 Million - $1.93 Million
19,992 Added 8.0%
269,971 $23.6 Million
Q2 2021

Aug 13, 2021

BUY
$76.44 - $89.57 $761,113 - $891,848
9,957 Added 4.15%
249,979 $22.4 Million
Q1 2021

Apr 21, 2021

BUY
$67.36 - $80.76 $16.2 Million - $19.4 Million
240,022 New
240,022 $18.2 Million

Others Institutions Holding SYNH

About Syneos Health, Inc.


  • Ticker SYNH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 102,653,000
  • Description
  • Syneos Health, Inc. provides biopharmaceutical outsourcing solutions company in North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates through two segments, Clinical Solutions and Commercial Solutions. The Clinical Solutions segment offers services for the development of diagnostics, drugs, biologics, de...
More about SYNH
Track This Portfolio

Track Crestwood Advisors Group LLC Portfolio

Follow Crestwood Advisors Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Crestwood Advisors Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Crestwood Advisors Group LLC with notifications on news.